" class="no-js "lang="en-US"> Companies Archive - Medtech Alert
Friday, June 26, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Genprex | MTA

Genprex

View Company

 Alnylam | MTA

Alnylam

View Company

 Life Biosciences | MTA

Life Biosciences

View Company

 Sherlock Biosciences | MTA

Sherlock Biosciences

View Company

 Genome Insight | MTA

Genome Insight

View Company

 Synthego | MTA

Synthego

View Company

 Coeptis Therapeutics | MTA

Coeptis Therapeutics

View Company

 MIMETAS | MTA

MIMETAS

View Company

 Sonoma Biotherapeutics | MTA

Sonoma Biotherapeutics

View Company

 CRISPR Therapeutics | MTA

CRISPR Therapeutics

Load More Results